COMPARATIVE EFFECTIVENESS OF PLATINUM PLUS PACLITAXEL, PLATINUM PLUS LIPOSOMAL DOXORUBICIN, TOPOTECAN, AND LIPOSOMAL DOXORUBICIN FOR SECOND-LINE CHEMOTHERAPY AMONG PLATINUM-SENSITIVE PATIENTS WITH RECURRENT ADVANCED OVARIAN CANCER IN TAIWAN

Huang H.; Tang C.; Cheng W.; You S.; Chiang C.; Chen Y.

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >COMPARATIVE EFFECTIVENESS OF PLATINUM PLUS PACLITAXEL, PLATINUM PLUS LIPOSOMAL DOXORUBICIN, TOPOTECAN, AND LIPOSOMAL DOXORUBICIN FOR SECOND-LINE CHEMOTHERAPY AMONG PLATINUM-SENSITIVE PATIENTS WITH RECURRENT ADVANCED OVARIAN CANCER IN TAIWAN

【24h】

COMPARATIVE EFFECTIVENESS OF PLATINUM PLUS PACLITAXEL, PLATINUM PLUS LIPOSOMAL DOXORUBICIN, TOPOTECAN, AND LIPOSOMAL DOXORUBICIN FOR SECOND-LINE CHEMOTHERAPY AMONG PLATINUM-SENSITIVE PATIENTS WITH RECURRENT ADVANCED OVARIAN CANCER IN TAIWAN

机译：铂铂加紫杉醇，普至铂和台湾铂敏感患者二线化疗铂钙和脂质体多柔比星的比较效果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2017年第5期|共1页
作者
Huang H.; Tang C.; Cheng W.; You S.; Chiang C.; Chen Y.;
展开▼
作者单位

Taipei Med Univ Taipei Taiwan;

Taipei Med Univ Taipei Taiwan;

Natl Taiwan Univ Hosp Taipei Taiwan;

Fu Jen Catholic Univ Taipei Taiwan;

Natl Taiwan Univ Taipei Taiwan;

Taiwan Blood Serv Fdn Taipei Taiwan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. COMPARATIVE EFFECTIVENESS OF PLATINUM PLUS PACLITAXEL, PLATINUM PLUS LIPOSOMAL DOXORUBICIN, TOPOTECAN, AND LIPOSOMAL DOXORUBICIN FOR SECOND-LINE CHEMOTHERAPY AMONG PLATINUM-SENSITIVE PATIENTS WITH RECURRENT ADVANCED OVARIAN CANCER IN TAIWAN [J] . Huang H., Tang C., Cheng W., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：铂铂加紫杉醇，普至铂和台湾铂敏感患者二线化疗铂钙和脂质体多柔比星的比较效果
2. Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma [J] . M. Hartmann, M. Fedders, A. Schneider, Journal of Cancer Research and Clinical Oncology . 2007,第9期

机译：马尔可夫模型用于铂类药物和紫杉醇一线化疗以及托泊替康和脂质体阿霉素作为上皮卵巢癌的二线化疗
3. Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma [J] . M. Fedders, M. Hartmann, A. Schneider, Journal of Cancer Research and Clinical Oncology . 2007,第12期

机译：马尔可夫模型用于铂类药物和紫杉醇一线化疗以及托泊替康和脂质体阿霉素作为上皮卵巢癌的二线化疗
4. Acoustic Cluster Therapy displays theranostic capability in enhancing the effectiveness of liposomal doxorubicin treatment of human triple negative breast cancer in mice [C] . Nigel Bush, Andrew Healey, Anant Shah, IEEE International Ultrasonics Symposium . 2019

机译：声学聚类疗法在提高小鼠中提高人类三重阴性乳腺癌的脂质体Doxorubicin治疗的有效性方面的治疗能力
5. Cost effectiveness of liposomal doxorubicin versus paclitaxel for the treatment of advanced AIDS-related Kaposis Sarcoma. [D] . Raimundo, Karina Pupio. 2011

机译：脂质体阿霉素与紫杉醇在治疗晚期艾滋病相关的卡波西斯肉瘤中的成本效益。
6. Retrospective Analysis Of Comparative Outcomes In Recurrent Platinum-Sensitive Ovarian Cancer Treated With Pegylated Liposomal Doxorubicin (Lipo-Dox) And Carboplatin Versus Paclitaxel And Carboplatin [O] . Chia-Sui Weng, Chao-Chih Wu, Tze-Chien Chen, 2019

机译：聚乙二醇化脂质体阿霉素（Lipo-Dox）和卡铂与紫杉醇和卡铂治疗复发的铂敏感性卵巢癌的比较结果的回顾性分析
7. A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer. [O] . Vergote, Ignace, Schilder, Russell J., Pippitt, Charles H. Jr, 2014

机译：trebananib联合聚乙二醇化脂质体阿霉素或托泊替康治疗复发性铂耐药或部分铂敏感的卵巢癌女性的1b期临床研究。

COMPARATIVE EFFECTIVENESS OF PLATINUM PLUS PACLITAXEL, PLATINUM PLUS LIPOSOMAL DOXORUBICIN, TOPOTECAN, AND LIPOSOMAL DOXORUBICIN FOR SECOND-LINE CHEMOTHERAPY AMONG PLATINUM-SENSITIVE PATIENTS WITH RECURRENT ADVANCED OVARIAN CANCER IN TAIWAN

著录项

相似文献

相关主题

期刊订阅